Order Article Reprints

Adel M, Elsayed HRH, El-Nablaway M, Hamed S, Eladl A, Fouad S, El Nashar EM, Al-Otaibi ML, Rabei MR. Targeting Hydrogen Sulfide Modulates Dexamethasone-Induced Muscle Atrophy and Microvascular Rarefaction, through Inhibition of NOX4 and Induction of MGF, M2 Macrophages and Endothelial Progenitors. Cells. 2022; 11(16):2500. https://doi.org/10.3390/cells11162500

Adel, Mohamed, Hassan Reda Hassan Elsayed, Mohammad El-Nablaway, Shereen Hamed, Amira Eladl, Samah Fouad, Eman Mohamad El Nashar, Mohammed Lafi Al-Otaibi, and Mohammed R. Rabei. 2022. "Targeting Hydrogen Sulfide Modulates Dexamethasone-Induced Muscle Atrophy and Microvascular Rarefaction, through Inhibition of NOX4 and Induction of MGF, M2 Macrophages and Endothelial Progenitors" Cells 11, no. 16: 2500. https://doi.org/10.3390/cells11162500

Adel, M., Elsayed, H. R. H., El-Nablaway, M., Hamed, S., Eladl, A., Fouad, S., El Nashar, E. M., Al-Otaibi, M. L., & Rabei, M. R. (2022). Targeting Hydrogen Sulfide Modulates Dexamethasone-Induced Muscle Atrophy and Microvascular Rarefaction, through Inhibition of NOX4 and Induction of MGF, M2 Macrophages and Endothelial Progenitors. Cells, 11(16), 2500. https://doi.org/10.3390/cells11162500